Vanguard Group’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $307M | Sell |
|
|||||
|
2025
Q2 | $245M | Buy |
|
|||||
|
2025
Q1 | $143M | Buy |
|
|||||
|
2024
Q4 | $197M | Buy |
|
|||||
|
2024
Q3 | $225M | Sell |
|
|||||
|
2024
Q2 | $144M | Buy |
|
|||||
|
2024
Q1 | $192M | Buy |
|
|||||
|
2023
Q4 | $102M | Buy |
|
|||||
|
2023
Q3 | $54.6M | Buy |
|
|||||
|
2023
Q2 | $86.1M | Buy |
|
|||||
|
2023
Q1 | $111M | Buy |
|
|||||
|
2022
Q4 | $91.4M | Buy |
|
|||||
|
2022
Q3 | $62.3M | Sell |
|
|||||
|
2022
Q2 | $56.6M | Buy |
|
|||||
|
2022
Q1 | $120M | Sell |
|
|||||
|
2021
Q4 | $188M | Buy |
|
|||||
|
2021
Q3 | $170M | Buy |
|
|||||
|
2021
Q2 | $99.1M | Buy |
|
|||||
|
2021
Q1 | $67.3M | Buy |
|
|||||
|
2020
Q4 | $38.6M | Buy |
|
|||||
|
2020
Q3 | $15.1M | Buy |
|